INCY 8-K: SEC filing

Incyte

Filed with the SEC on Nov 13, 2026 · accession 0000879169-26-000068

INCY filed a 8-K (current report) with the SEC on Nov 13, 2026. Incyte announced it will not proceed with the planned Phase 3 MAESTRA-3 study of INCB123667 in combination with bevacizumab for first-line maintenance therapy in ovarian cancer, citing portfolio prioritization rather than safety or efficacy concerns. The stock moved -0.6% by the first close after the filing.

Summary of the filing

Incyte announced it will not proceed with the planned Phase 3 MAESTRA-3 study of INCB123667 in combination with bevacizumab for first-line maintenance therapy in ovarian cancer, citing portfolio prioritization rather than safety or efficacy concerns. The company stated the decision does not affect its financial guidance or long-term outlook.

For details, click here →How to read a 8-K →

Key details

RegistrantIncyte Corporation

Executive vice president and general counselRichard Hoffman

How INCY stock reacted

Close before

$121.70

Nov 12, 2026

First close after

-0.60%

$120.97

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for INCY, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for INCY?

Click here

Frequently asked questions

What did INCY file with the SEC on Nov 13, 2026?

INCY filed a 8-K (SEC filing). Incyte announced it will not proceed with the planned Phase 3 MAESTRA-3 study of INCB123667 in combination with bevacizumab for first-line maintenance therapy in ovarian cancer, citing portfolio prioritization rather than safety or efficacy concerns. The company stated the decision does not affect its financial guidance or long-term outlook.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did INCY stock react to this filing?

INCY closed at $121.70 before the filing and $120.97 on Nov 13, 2026 (-0.60%).

Other INCY SEC filings

Get alerts when INCY files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

INCY overview INCY analysis INCY news Latest SEC filings